Side-by-side comparison of AI visibility scores, market position, and capabilities
AI platform repurposing long-form content into social media clips with auto-captions, highlights, and branded templates.
Vidyo.ai is an AI-powered video repurposing platform that helps content creators, marketers, and social media managers transform long videos into short clips for distribution across social media channels. The platform uses AI to extract key moments from lengthy recordings, automatically adds captions, applies branded templates, and resizes clips to the correct aspect ratio for each social platform. Vidyo.ai is designed for marketing teams that produce regular video content — webinars, product demos, interviews, event recordings — and need to efficiently repurpose that content for social media without a dedicated video editor. The tool supports direct publishing to YouTube, TikTok, LinkedIn, and Instagram, streamlining the entire short-form content workflow from repurposing to distribution. Founded in 2021, Vidyo.ai has grown through product-led adoption and serves thousands of marketers and content teams globally. The company competes with OpusClip, Munch, and Repurpose.io in the AI video repurposing market, differentiating through its branded template library and multi-platform publishing capabilities.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.